296 related articles for article (PubMed ID: 27817855)
1. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
2. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.
Arbouw ME; Movig KL; Egberts TC; Poels PJ; van Vugt JP; Wessels JA; van der Straaten RJ; Neef C; Guchelaar HJ
Eur J Clin Pharmacol; 2009 Dec; 65(12):1245-51. PubMed ID: 19669131
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
[TBL] [Abstract][Full Text] [Related]
7. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
8. Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
Rieck M; Schumacher-Schuh AF; Altmann V; Callegari-Jacques SM; Rieder CRM; Hutz MH
Pharmacogenomics J; 2018 Jan; 18(1):196-200. PubMed ID: 27779245
[TBL] [Abstract][Full Text] [Related]
9. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
Paus S; Gadow F; Knapp M; Klein C; Klockgether T; Wüllner U
Mov Disord; 2009 May; 24(7):1080-4. PubMed ID: 19353703
[TBL] [Abstract][Full Text] [Related]
10. Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.
Dos Santos EUD; Duarte EBC; Miranda LMR; Asano AGC; Asano NMJ; Maia MMD; de Souza PRE
Neuromolecular Med; 2019 Sep; 21(3):295-302. PubMed ID: 31119645
[TBL] [Abstract][Full Text] [Related]
11. Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.
Zhang R; Li J; Wu Y; Liang S; Xu L
Genet Test Mol Biomarkers; 2021 Jan; 25(1):20-30. PubMed ID: 33372861
[No Abstract] [Full Text] [Related]
12. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents.
Bombin I; Arango C; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; Gonzalez-Gomez C; Moreno D; Parellada M; Baeza I; Graell M; Otero S; Saiz PA; Patiño-Garcia A
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):873-9. PubMed ID: 18351593
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
14. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
[TBL] [Abstract][Full Text] [Related]
15. Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism.
Paus S; Gadow F; Kaut O; Knapp M; Klein C; Klockgether T; Wüllner U
Parkinsonism Relat Disord; 2010 Jul; 16(6):381-3. PubMed ID: 20434388
[TBL] [Abstract][Full Text] [Related]
16. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
17. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
[TBL] [Abstract][Full Text] [Related]
18. Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence.
Ragia G; Veresies I; Veresie L; Veresies K; Manolopoulos VG
Drug Metab Pers Ther; 2016 Sep; 31(3):143-50. PubMed ID: 27447243
[TBL] [Abstract][Full Text] [Related]
19. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
[TBL] [Abstract][Full Text] [Related]
20. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J
Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
